Welcome to our dedicated page for Tilt Hldgs news (Ticker: TLLTF), a resource for investors and traders seeking the latest updates and insights on Tilt Hldgs stock.
TILT Holdings Inc. (TLLTF) generates a wide range of company news tied to its role as a global provider of cannabis business solutions. Its disclosures describe a portfolio that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, with a core focus on Jupiter Research LLC, a wholly owned subsidiary active in vaporization hardware design, research, development, manufacturing and distribution. News about TILT often highlights how these activities support cannabis brands and retailers across North America, South America, Israel and the European Union.
Recent announcements show that TILT’s news flow covers both operational performance and strategic restructuring. Earnings releases discuss quarterly financial and operating results, including revenue trends, gross margin dynamics and the impact of strategic shifts such as divesting plant-touching assets in Massachusetts and Ohio or transitioning parts of Jupiter’s business to a commission-based model. Operational updates also describe regulatory approvals, such as European Union medical device certification for a handheld liquid inhalation device developed by Jupiter, and agreements with partners like Curaleaf International for commercialization in medical markets.
Another important stream of news relates to capital structure and creditor arrangements. TILT has reported entering into secured note purchase agreements for bridge financing, receiving default notices from landlords on certain cultivation properties, and negotiating forbearance arrangements. The company has also issued multiple releases about its CCAA restructuring process in the Supreme Court of British Columbia, including the initial order granting creditor protection, the proposed plan of arrangement to take the company private, and notices of meetings for noteholders.
For users following TLLTF on this news page, the coverage provides a consolidated view of TILT’s financial results, restructuring milestones, asset sales, regulatory certifications and governance events such as shareholder meeting outcomes. Investors and observers can use this archive to trace how TILT’s strategy has evolved toward Jupiter-centered, asset-light operations and to understand the context behind its delisting and restructuring decisions.
TILT Holdings Inc. (Cboe: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions, has announced its upcoming second quarter 2024 conference call scheduled for August 9, 2024, at 8:30 a.m. Eastern Time. The call will discuss the company's business strategy and financial results for the quarter ended June 30, 2024. TILT management will host the call, followed by a question-and-answer session. The company's results will be reported in a press release prior to the call. Interested parties can join via phone or webcast, with replay available in the investor relations section of TILT's website.
TILT Holdings announced the outcomes of its 2024 Annual General Meeting held virtually on June 11, 2024. Shareholders approved the election of five directors: John Barravecchia, Tim Conder, Adam Draizin, George Odden, and Arthur Smuck, who will serve until the next AGM. Additionally, Macias Gini & O’Connell LLP (MGO) was re-appointed as the company's auditor for the upcoming year, and the board received authorization to set MGO's remuneration. A detailed report of voting results has been filed on SEDAR+.
TILT Holdings reported its Q1 2024 financial results, revealing a revenue of $37.5 million, down from $42.3 million in Q1 2023 due to lower sales volumes and price compression in Massachusetts and Pennsylvania. The gross profit stood at $6.7 million with a margin of 17.9%, compared to $8.8 million and 20.8% respectively from the previous year. The net loss widened to $9.7 million, primarily due to a reduced gross profit and no asset sales gains as in Q1 2023. Adjusted EBITDA improved slightly to $38,000 from $(79,000). Operational highlights included the launch of the Level brand in Pennsylvania and winning the NECANN Cup for best vape cartridge. TILT is focusing on strengthening its balance sheet and addressing debt in 2024, despite ongoing industry challenges.
TILT Holdings Inc. secures funding for its Pennsylvania subsidiary, Standard Farms, to develop and operate three medical marijuana dispensaries in the Commonwealth of Pennsylvania under a new permit. The funding, up to $10.5 million, is provided by an experienced retailer and operator. The Note will bear interest at 20% initially, increasing to 30% and then 40% as milestones are achieved. The loan is secured by Standard Farms' retail assets and equity interests held by Baker Technologies, Inc.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.